BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Allergy to pollen
,
Leukocyte
,
DNA fingerprint
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Isentress
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
A Health Literate Patient-focused Approach to the Redesign of the Raltegravir (ISENTRESS) Pediatric …
Optimal use of raltegravir (Isentress(R)) in the treatment of HIV-infected adults - Canadian consens…
Evaluation of the effect of short-term treatment with the integrase inhibitor raltegravir (Isentress…
Quantitative prediction of human clearance guiding the development of Raltegravir (MK-0518, isentres…
A Review on Pharmacokinetics Properties of Antiretroviral Drugs to Treat HIV-1 Infections.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Isentress Re-examination Study (MK-0518-115)
Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Thir…
Effects of Raltegravir (Isentress®) on Lipid and Carbohydrate Metabolism and Mitochondrial Function …
QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ